These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10500267)

  • 1. Altered brain metabolism in the C57BL/Wld mouse strain detected by magnetic resonance spectroscopy: association with delayed Wallerian degeneration?
    Tsao JW; Paramananthan N; Parkes HG; Dunn JF
    J Neurol Sci; 1999 Sep; 168(1):1-12. PubMed ID: 10500267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse.
    Tsao JW; Brown MC; Carden MJ; McLean WG; Perry VH
    Eur J Neurosci; 1994 Apr; 6(4):516-24. PubMed ID: 8025707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
    Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
    Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
    Shen H; Hyrc KL; Goldberg MP
    Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
    Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
    Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.
    Almasieh M; Catrinescu MM; Binan L; Costantino S; Levin LA
    J Neurosci; 2017 Apr; 37(14):3824-3839. PubMed ID: 28275163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS.
    Fang C; Bernardes-Silva M; Coleman MP; Perry VH
    Neuroscience; 2005; 135(4):1107-18. PubMed ID: 16154290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration, and regeneration in normal mice.
    Myers RR; Heckman HM; Rodriguez M
    Exp Neurol; 1996 Sep; 141(1):94-101. PubMed ID: 8797671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature modulation reveals three distinct stages of Wallerian degeneration.
    Tsao JW; George EB; Griffin JW
    J Neurosci; 1999 Jun; 19(12):4718-26. PubMed ID: 10366605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.
    Xie M; Wang Q; Wu TH; Song SK; Sun SW
    Neuroscience; 2011 Dec; 197():339-47. PubMed ID: 21964470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion disease development in slow Wallerian degeneration (Wld(S)) mice.
    Gültner S; Laue M; Riemer C; Heise I; Baier M
    Neurosci Lett; 2009 Jun; 456(2):93-8. PubMed ID: 19429141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.
    Wright AK; Wishart TM; Ingham CA; Gillingwater TH
    PLoS One; 2010 Nov; 5(11):e15108. PubMed ID: 21124744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.
    Parson SH; Ribchester RR; Davie N; Gandhi NP; Malik RQ; Gillingwater TH; Thomson D
    J Neurosci Res; 2004 Apr; 76(1):64-75. PubMed ID: 15048930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
    Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarm1 Deletion, but Not Wld
    Gilley J; Ribchester RR; Coleman MP
    Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG.
    Ramer MS; French GD; Bisby MA
    Pain; 1997 Aug; 72(1-2):71-8. PubMed ID: 9272789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell body response to injury in motoneurons and primary sensory neurons of a mutant mouse, Ola (Wld), in which Wallerian degeneration is delayed.
    Bisby MA; Tetzlaff W; Brown MC
    J Comp Neurol; 1995 Sep; 359(4):653-62. PubMed ID: 7499554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.
    Wishart TM; Brownstein DG; Thomson D; Tabakova AM; Boothe KM; Tsao JW; Gillingwater TH
    BMC Neurosci; 2009 Dec; 10():148. PubMed ID: 20015399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.